首页> 美国卫生研究院文献>BMC Health Services Research >Patient-centered comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy
【2h】

Patient-centered comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy

机译:以患者为中心的食道癌筛查的相对有效性:一项比较有效性研究的协议旨在为基于证据的筛查和监测内窥镜检查方法提供指导

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe comparative effectiveness (CE) of endoscopic screening (versus no screening) for Barrett’s esophagus (BE) in patients with GERD symptoms, or among different endoscopic surveillance strategies in patients with BE, for the early detection of esophageal adenocarcinoma (EA) is unknown. Furthermore, it is unclear if patients or providers have or will adopt any of these strategies (screening only, screening and surveillance, vs. none), irrespective of their effectiveness. Endoscopic screening and surveillance is expensive and can be risky. Therefore, it is imperative to establish the CE and acceptability about the risks and outcomes related to these practices to better inform expert recommendations and provider-patient decisions.
机译:背景内镜筛查(相对于无筛查)在具有GERD症状的患者中或在BE患者的不同内窥镜监测策略中对早期发现食管腺癌(EA)的比较效果(CE)尚不明确。此外,尚不清楚患者或提供者是否会或将采取任何这些策略(仅筛查,筛查和监测,而不选择筛查),无论其有效性如何。内窥镜检查和监视很昂贵并且可能有风险。因此,必须建立与这些实践相关的风险和结果的CE和可接受性,以更好地为专家建议和提供者-患者的决策提供依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号